Stanley Chang
Amministratore Delegato presso MEDIGEN BIOTECHNOLOGY CORP.
Profilo
Shih Chung Chang is currently the Chairman & Chief Executive Officer at Medigen Biotechnology Corp., Chairman at Winston Medical Supply Co., Ltd., Chairman at Medigen Vaccine Biologics Corp., Non-Executive Director at TBG Diagnostics Ltd., Director at TBG, Inc. (Taiwan), Director at TBG Biotechnology, Inc., and Director at UMO International Co., Ltd.
Previously, he held positions as Director at Development Center for Biotechnology, Director at Medigreen Biotechnology Corp., President at Ameribankers Corp., and Professor at Tzu Chi University.
He holds a doctorate degree from University College London and an undergraduate degree from National Taiwan University College of Medicine.
Posizioni attive di Stanley Chang
Società | Posizione | Inizio |
---|---|---|
TBG DIAGNOSTICS LIMITED | Direttore/Membro del Consiglio | - |
MEDIGEN BIOTECHNOLOGY CORP. | Amministratore Delegato | 09/06/2003 |
MEDIGEN VACCINE BIOLOGICS CORPORATION | Presidente | 12/12/2012 |
WINSTON MEDICAL SUPPLY CO., LTD. | Presidente | 07/02/2014 |
TBG Biotechnology, Inc. | Direttore/Membro del Consiglio | - |
UMO International Co., Ltd. | Direttore/Membro del Consiglio | - |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Stanley Chang
Società | Posizione | Fine |
---|---|---|
Ameribankers Corp. | Presidente | 01/01/2000 |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Direttore/Membro del Consiglio | - |
░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Stanley Chang
University College London | Doctorate Degree |
National Taiwan University College of Medicine | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
MEDIGEN BIOTECHNOLOGY CORP. | Health Technology |
MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
WINSTON MEDICAL SUPPLY CO., LTD. | Health Technology |
Aziende private | 7 |
---|---|
TBG Diagnostics Ltd.
TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
Ameribankers Corp. | |
Medigreen Biotechnology Corp.
Medigreen Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Medigreen Biotechnology Corporation, founded on April 10th, 2002, is focusing on the development of botanical new drugs and is established by domestic and overseas outstanding enterprises and entrepreneurs, in accordance with the government's promotion policy, to develop the Chinese Traditional Medicine industry. The major stockholders of Medigreen include Medigen Biotechnology Corp., SunTen Phytotech Co., Ltd. and YFY Biotech Management Company, etc. Since the foundation, based on the mission of 'contribution to the human health' and on the main principle of the immunologic system, Medigreen has been worked on the R & D of new botanical drugs on 'cancer adjuvant', 'anti-ulcer' and 'respiratory tract diseases'. Medigreen develops diverse functional products and ingredients on the base of the Traditional Chinese Medicine theory, the concept of 'medicine and food from the same source', and the efficacy examination of biotechnology followed the new drug development process to contribute to the human health and to guarantee the persistent progress of the enterprise during the new drug development. | Health Technology |
Development Center for Biotechnology
Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Health Services |
TBG Biotechnology, Inc. | |
UMO International Co., Ltd. | |
TBG, Inc. (Taiwan)
TBG, Inc. (Taiwan) Financial ConglomeratesFinance TBG, Inc. operates as an investment holding company. The company is headquartered in Taipei, Taiwan. | Finance |
- Borsa valori
- Insiders
- Stanley Chang